• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在对人类志愿者进行为期7天的环丙沙星给药过程中环丙沙星的药代动力学及粪便菌群的变化。

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.

作者信息

Brumfitt W, Franklin I, Grady D, Hamilton-Miller J M, Iliffe A

出版信息

Antimicrob Agents Chemother. 1984 Nov;26(5):757-61. doi: 10.1128/AAC.26.5.757.

DOI:10.1128/AAC.26.5.757
PMID:6517559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC180008/
Abstract

Twelve male subjects, aged 19 to 40 years, shown to be healthy by examination and laboratory tests, took 500 mg of ciprofloxacin every 12 h for 7 days. After the first and the last dose, blood and urine samples were taken and drug concentrations were determined by bioassay. There was a significant buildup in mean concentrations in serum from day 1 to day 7; mean peak levels (attained after 1 to 2 h) were 1.9 and 2.8 micrograms/ml, respectively. The terminal half-life was 3.5 to 4 h. About 40% of the drug was excreted into the urine during the 12-h period after dosing; minimum mean concentrations in urine were 105 micrograms/ml on day 1 and 174 micrograms/ml on day 7. Considerable amounts of ciprofloxacin were found in the feces on day 7 (185 to 2,220 micrograms/g). Marked changes in the aerobic part of the fecal flora were observed as a result of taking ciprofloxacin: coliforms were absent on day 7, and concentrations of streptococci and staphylococci were significantly reduced. There was no overgrowth by yeasts. One week later the fecal flora had returned to a state similar to that found before treatment. Anaerobes were little affected quantitatively but acquired resistance to ciprofloxacin. Side effects were mild and transient.

摘要

12名年龄在19至40岁之间的男性受试者,经体格检查和实验室检测显示健康,每12小时服用500毫克环丙沙星,持续7天。在首次和末次给药后,采集血样和尿样,并通过生物测定法测定药物浓度。从第1天到第7天,血清中的平均浓度有显著升高;平均峰值水平(在1至2小时后达到)分别为1.9和2.8微克/毫升。终末半衰期为3.5至4小时。给药后12小时内,约40%的药物经尿液排出;第1天尿液中的最低平均浓度为105微克/毫升,第7天为174微克/毫升。在第7天的粪便中发现了大量环丙沙星(185至2220微克/克)。服用环丙沙星导致粪便需氧菌群发生显著变化:第7天未检测到大肠菌群,链球菌和葡萄球菌的浓度显著降低。未出现酵母菌过度生长的情况。一周后,粪便菌群恢复到治疗前的类似状态。厌氧菌在数量上受影响较小,但获得了对环丙沙星的耐药性。副作用轻微且短暂。

相似文献

1
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.在对人类志愿者进行为期7天的环丙沙星给药过程中环丙沙星的药代动力学及粪便菌群的变化。
Antimicrob Agents Chemother. 1984 Nov;26(5):757-61. doi: 10.1128/AAC.26.5.757.
2
Effect of oral ciprofloxacin on the faecal flora of healthy volunteers.口服环丙沙星对健康志愿者粪便菌群的影响。
Eur J Clin Microbiol. 1986 Apr;5(2):201-5. doi: 10.1007/BF02013987.
3
Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.环丙沙星在正常志愿者中的多剂量药代动力学及安全性
Antimicrob Agents Chemother. 1984 Nov;26(5):741-4. doi: 10.1128/AAC.26.5.741.
4
Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora.环丙沙星的药代动力学及重复给药对唾液和粪便微生物群的影响。
Antimicrob Agents Chemother. 1986 Feb;29(2):298-302. doi: 10.1128/AAC.29.2.298.
5
[Ciprofloxacine: evaluation of its biliary elimination in man].
Schweiz Med Wochenschr. 1985 Mar 30;115(13):448-53.
6
Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate.静脉注射环丙沙星与硫糖铝同时给药时对需氧肠道微生物群及粪便药物水平的影响。
Antimicrob Agents Chemother. 1997 Aug;41(8):1725-30. doi: 10.1128/AAC.41.8.1725.
7
Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.口服和静脉注射后环丙沙星在健康志愿者体内的药代动力学。
Eur J Clin Microbiol. 1986 Apr;5(2):179-86. doi: 10.1007/BF02013983.
8
Pharmacokinetics of ciprofloxacin after oral and parenteral administration.口服和肠胃外给药后环丙沙星的药代动力学。
Antimicrob Agents Chemother. 1985 Mar;27(3):375-9. doi: 10.1128/AAC.27.3.375.
9
Pharmacokinetics of ciprofloxacin in elderly subjects.
Pharmacotherapy. 1986 Mar-Apr;6(2):87-91. doi: 10.1002/j.1875-9114.1986.tb03458.x.
10
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.标准早餐对环丙沙星药物吸收及多剂量药代动力学的影响。
Antimicrob Agents Chemother. 1985 Mar;27(3):350-2. doi: 10.1128/AAC.27.3.350.

引用本文的文献

1
-Associated Antibiotics Alter Human Mucosal Barrier Functions by Microbiome-Independent Mechanisms.-抗生素通过微生物组独立机制改变人类黏膜屏障功能。
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.01404-19.
2
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life.一个描述环丙沙星药代动力学在整个生命周期内的生理基于药代动力学模型。
Clin Pharmacokinet. 2018 Dec;57(12):1613-1634. doi: 10.1007/s40262-018-0661-6.
3
Detection of Ciprofloxacin in Urine through Sensitized Lanthanide Luminescence.通过敏化镧系元素发光检测尿液中的环丙沙星。
Sensors (Basel). 2016 Dec 5;16(12):2065. doi: 10.3390/s16122065.
4
Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection.艰难梭菌的抗药性和耐药性降低:对艰难梭菌感染的诱导、治疗和复发的潜在影响。
Antibiotics (Basel). 2015 Jul 10;4(3):267-98. doi: 10.3390/antibiotics4030267.
5
Human gut microbiota: repertoire and variations.人类肠道微生物组:组成和变化。
Front Cell Infect Microbiol. 2012 Nov 2;2:136. doi: 10.3389/fcimb.2012.00136. eCollection 2012.
6
Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral ceftriaxone therapy does not.口服环丙沙星治疗会损害鼠伤寒沙门氏菌腹泻模型中保护性免疫应答的产生,而注射用头孢曲松治疗则不会。
Antimicrob Agents Chemother. 2012 May;56(5):2295-304. doi: 10.1128/AAC.05819-11. Epub 2012 Feb 21.
7
Effect of early and late antibiotic treatment in experimental acute pancreatitis in rats.早期和晚期抗生素治疗对大鼠实验性急性胰腺炎的影响。
Langenbecks Arch Surg. 2007 May;392(3):365-70. doi: 10.1007/s00423-007-0166-5. Epub 2007 Mar 23.
8
Effect of parenteral fluoroquinolone administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract.肠胃外给予氟喹诺酮对耐万古霉素屎肠球菌在小鼠胃肠道中持续性的影响。
Antimicrob Agents Chemother. 2004 Jan;48(1):326-8. doi: 10.1128/AAC.48.1.326-328.2004.
9
Effects of single oral doses of gemifloxacin (320 milligrams) versus trovafloxacin (200 milligrams) on fecal flora in healthy volunteers.单次口服吉米沙星(320毫克)与曲伐沙星(200毫克)对健康志愿者粪便菌群的影响。
Antimicrob Agents Chemother. 2001 Feb;45(2):608-11. doi: 10.1128/AAC.45.2.608-611.2001.
10
Effect of quinolones on intestinal ecology.喹诺酮类药物对肠道生态的影响。
Drugs. 1999;58 Suppl 2:65-70. doi: 10.2165/00003495-199958002-00013.

本文引用的文献

1
Treatment of urinary-tract infections with amphicillin. A clinical trial.氨苄青霉素治疗尿路感染。一项临床试验。
Lancet. 1962 Jan 20;1(7221):130-3. doi: 10.1016/s0140-6736(62)91132-7.
2
Rifaprim (rifampicin plus trimethoprim): pharmacokinetics and effects on the normal flora of man.
Biopharm Drug Dispos. 1981 Apr-Jun;2(2):157-66. doi: 10.1002/bdd.2510020208.
3
Colonization resistance of the digestive tract: clinical consequences and implications.消化道的定植抗性:临床后果及影响
J Antimicrob Chemother. 1982 Oct;10(4):263-70. doi: 10.1093/jac/10.4.263.
4
Pharmacokinetics and tissue penetration of ciprofloxacin.环丙沙星的药代动力学及组织穿透性
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.
5
Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans.甲磺酸培氟沙星在小鼠、大鼠、犬、猴及人体内的吸收、分布、代谢转归及消除
Antimicrob Agents Chemother. 1984 Apr;25(4):463-72. doi: 10.1128/AAC.25.4.463.
6
In-vitro studies with ciprofloxacin, a new 4-quinolone compound.使用新型4-喹诺酮化合物环丙沙星进行的体外研究。
J Antimicrob Chemother. 1984 Apr;13(4):333-46. doi: 10.1093/jac/13.4.333.
7
The pharmacokinetics and tissue penetration of norfloxacin.诺氟沙星的药代动力学及组织穿透性。
J Antimicrob Chemother. 1984 Jan;13(1):87-92. doi: 10.1093/jac/13.1.87.
8
In vitro activity of ciprofloxacin (Bay o 9867).环丙沙星(拜耳o 9867)的体外活性。
Antimicrob Agents Chemother. 1983 Oct;24(4):568-74. doi: 10.1128/AAC.24.4.568.
9
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.新型喹啉衍生物Bay 09867与其他抗菌药物的体外活性比较。
Antimicrob Agents Chemother. 1983 Apr;23(4):559-64. doi: 10.1128/AAC.23.4.559.
10
Transport and storage of faeces for bacteriological examination.用于细菌学检查的粪便运输与储存。
J Appl Bacteriol. 1971 Jun;34(2):477-83. doi: 10.1111/j.1365-2672.1971.tb02307.x.